Clinical Trials
22 trialsTQB2223 Injection in Combination With Penpulimab in Patients With Advanced Cancers
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
FOCUSau
University of Melbourne
HALO-Trak
University College, London
AST-021p Study in Advanced Solid Tumors
Aston Sci. Inc.
PETUPAL
University Hospital Heidelberg
Enhanced Supportive Care for Advanced Cancer Patients: Evaluation of Standardized Care Pathway
Yonsei University
Clinical Trial of the TQB2928 Injection in Patients With Advanced Cancers
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
A Clinical Study of TQB3824 in Subjects With Advanced Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
A ProspectiveTrial Using Video Images in Advance Care Planning in Hospitalized Seriously Ill Patients With Advanced Cancer
Massachusetts General Hospital
A Prospective Dose Finding Study of Iscador Infusion
HaEmek Medical Center, Israel
Adjunctive Effect of Acupuncture for Advanced Cancer Patients With Palliative Care: a Three-arm Randomized Trial
The University of Hong Kong
ovarian cancer
Assiut University
Clinical Study of Granulocyte Infusion for Advanced Cancer
Shanghai East Hospital
A Study of AL2846 on Tolerance and Pharmacokinetics
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
A Phase I Study of TQ-B3234 on Tolerance and Pharmacokinetics
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Treatment of Carrying TP53 Harmful Mutations
Tianjin Medical University Second Hospital
Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells
Hangzhou Cancer Hospital
A Phase I Study of TQ-B3101 on Tolerance and Pharmacokinetics
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
A Phase I Study of TQ-B3139 on Tolerance and Pharmacokinetics
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
HS:Hansoh;
Jiangsu Hansoh Pharmaceutical Co., Ltd.
A Study of Sinotecean on Tolerance and Pharmacokinetics
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Safety Study of FLP Injection to Treat Tumor Patients
Acea Bio (Hangzhou) Co., Ltd.